ÌÇÐÄÆƽâ°æ

Novartis

Statistics report about pharmaceutical company Novartis

This report presents key facts and figures about Swiss-based pharmaceutical company Novartis. Novartis International AG is one of the world's leading pharmaceutical companies. This report shows the company's role in global pharma, key financial figures, major segments and products, the competitive landscape, etc.

Download your Report

  We value your privacy and will never rent or sell your email address.

Privacy

Table of contents

Company positioning & scale

5
  • Premium Statistic Major 50 pharmaceutical companies - Rx sales and R&D spending 2024
  • Premium Statistic Leading 10 biotech and pharmaceutical companies based on market cap 2026
  • Premium Statistic Pharmaceutical companies — revenue from top 3 products 2024
  • Premium Statistic Novartis' revenue 2007-2025
  • Basic Statistic Novartis' number of full-time employees 2009-2025

Financial scale & structure

6
  • Premium Statistic Novartis' revenue by region 2017-2025
  • Basic Statistic Novartis' net income 2007-2025
  • Premium Statistic Novartis operating profit 2021-2025
  • Premium Statistic Novartis' gross profit by type 2019-2025
  • Premium Statistic Free cash flow of Novartis AG 2016-2025
  • Basic Statistic Novartis total assets 2021-2025

Portfolio, segments & geography

5
  • Premium Statistic Novartis revenue 2014-2025, by segment
  • Basic Statistic Novartis - revenue by market 2025
  • Basic Statistic Percentage of Novartis pharmaceuticals revenue by therapy area 2023-2025
  • Premium Statistic Novartis' major drugs based on revenue 2025
  • Premium Statistic Novartis AG's three major drugs 2021-2025, by sales share

Competitive landscape

5
  • Premium Statistic Pfizer revenue 2006-2025
  • Premium Statistic Merck & Co. revenue 2006-2025
  • Premium Statistic Johnson & Johnson revenue 2005-2025
  • Basic Statistic AbbVie revenue 2010-2025
  • Premium Statistic Roche Group's total sales 2006-2025

R&D, pipeline & innovation

5
  • Premium Statistic Total global pharmaceutical R&D spending 2016-2030
  • Premium Statistic Top pharma companies worldwide 2026, by size of R&D pipeline
  • Premium Statistic Novartis' expenditure on research and development 2004-2025
  • Premium Statistic Novartis' R&D expenditure as a percent of revenue 2004-2025
  • Premium Statistic Projects in the pipeline of Novartis AG Q4 2025, by phase

Outlook & risk

3
  • Basic Statistic Sales forecast of select Novartis R&D projects worldwide 2028
  • Basic Statistic AI readiness of big pharma companies 2025
  • Premium Statistic Major pharma companies by cardiovascular drug revenue worldwide 2023 and 2030
Report this content
FURTHER REPORTS

Recommended and recent reports

Recommended statistics

You may also be interested in...
We’re happy to help

Get in touch with us for additional information

Feel free to contact us anytime. We will respond to your inquiry as quickly as possible.

Get in touch